557 related articles for article (PubMed ID: 26972965)
1. Impact of insulin pump therapy on long-term glycemic control in a pediatric Spanish cohort.
Colino E; Martín-Frías M; Yelmo R; Álvarez MÁ; Roldán B; Barrio R
Diabetes Res Clin Pract; 2016 Mar; 113():69-76. PubMed ID: 26972965
[TBL] [Abstract][Full Text] [Related]
2. Does the timing of insulin pump therapy initiation after type 1 diabetes onset have an impact on glycemic control?
Shalitin S; Lahav-Ritte T; Lebenthal Y; Devries L; Phillip M
Diabetes Technol Ther; 2012 May; 14(5):389-97. PubMed ID: 22283639
[TBL] [Abstract][Full Text] [Related]
3. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
Pala L; Dicembrini I; Mannucci E
Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
[TBL] [Abstract][Full Text] [Related]
4. Continuous Subcutaneous Insulin Infusion in Adult Type 1 Diabetes Mellitus Patients: Results from a Public Health System.
Moreno-Fernandez J; Gomez FJ; Pinés P; González J; López J; López LM; Blanco B; Roa C; Herranz S; Muñoz-Rodríguez JR
Diabetes Technol Ther; 2019 Aug; 21(8):440-447. PubMed ID: 31199682
[No Abstract] [Full Text] [Related]
5. Does treatment with an insulin pump improve glycaemic control in children and adolescents with type 1 diabetes? A retrospective case-control study.
Brorsson AL; Viklund G; Örtqvist E; Lindholm Olinder A
Pediatr Diabetes; 2015 Nov; 16(7):546-53. PubMed ID: 25327782
[TBL] [Abstract][Full Text] [Related]
6. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
[TBL] [Abstract][Full Text] [Related]
7. Achievement of metabolic control goals set by the American Diabetes Association and the International Society for Pediatric and Adolescent Diabetes in pediatric patients with type 1 diabetes from Spain.
Enes P; Martín-Frías M; Álvarez MÁ; Yelmo R; Alonso M; Barrio R
Diabetes Res Clin Pract; 2015 Feb; 107(2):300-5. PubMed ID: 25595220
[TBL] [Abstract][Full Text] [Related]
8. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
[TBL] [Abstract][Full Text] [Related]
9. Improved glycemic control after long-term insulin pump use in pediatric patients with type 1 diabetes.
Scrimgeour L; Cobry E; McFann K; Burdick P; Weimer C; Slover R; Chase HP
Diabetes Technol Ther; 2007 Oct; 9(5):421-8. PubMed ID: 17931050
[TBL] [Abstract][Full Text] [Related]
10. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.
Alemzadeh R; Palma-Sisto P; Parton EA; Holzum MK
Diabetes Technol Ther; 2005 Aug; 7(4):587-96. PubMed ID: 16120030
[TBL] [Abstract][Full Text] [Related]
11. Continuous subcutaneous insulin infusion in toddlers and children with type 1 diabetes mellitus is safe and effective.
Mack-Fogg JE; Orlowski CC; Jospe N
Pediatr Diabetes; 2005 Mar; 6(1):17-21. PubMed ID: 15787897
[TBL] [Abstract][Full Text] [Related]
12. Glycemic, auxologic, and seasonal aspects of continuous subcutaneous insulin infusion therapy in children and young adults with type 1 diabetes.
Hathout EH; McClintock T; Sharkey J; Kytsenko D; Hartwick N; Hadley-Scofield M; Torgeson S; Mace JW
Diabetes Technol Ther; 2003; 5(2):175-81. PubMed ID: 12871607
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy of insulin pump therapy on glycemic control in adults with type 1 diabetes mellitus.
Orr CJ; Hopman W; Yen JL; Houlden RL
Diabetes Technol Ther; 2015 Jan; 17(1):49-54. PubMed ID: 25317602
[TBL] [Abstract][Full Text] [Related]
14. Budget impact of continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes who experience severe recurrent hypoglycemic episodes in Spain.
Giménez M; Elías I; Álvarez M; Quirós C; Conget I
Endocrinol Diabetes Nutr; 2017; 64(7):377-383. PubMed ID: 28745609
[TBL] [Abstract][Full Text] [Related]
15. Insulin pumps in pediatric routine care improve long-term metabolic control without increasing the risk of hypoglycemia.
Hanas R; Adolfsson P
Pediatr Diabetes; 2006 Feb; 7(1):25-31. PubMed ID: 16489971
[TBL] [Abstract][Full Text] [Related]
16. Difference in insulin usage patterns with pubertal development in children with type 1 diabetes during transition from multiple daily injections to continuous subcutaneous insulin infusion (CSII) and through the CSII treatment.
Shashaj B; Sulli N
Diabetes Technol Ther; 2009 Dec; 11(12):767-74. PubMed ID: 20001677
[TBL] [Abstract][Full Text] [Related]
17. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes.
Bode BW; Steed RD; Davidson PC
Diabetes Care; 1996 Apr; 19(4):324-7. PubMed ID: 8729154
[TBL] [Abstract][Full Text] [Related]
18. Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: decreased HbA1c with low risk of hypoglycemia.
Sulli N; Shashaj B
J Pediatr Endocrinol Metab; 2003 Mar; 16(3):393-9. PubMed ID: 12705364
[TBL] [Abstract][Full Text] [Related]
19. Benefits of continuous subcutaneous insulin infusion (CSII) therapy in preschool children.
Levy-Shraga Y; Lerner-Geva L; Modan-Moses D; Graph-Barel C; Mazor-Aronovitch K; Boyko V; Pinhas-Hamiel O
Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):225-9. PubMed ID: 23329580
[TBL] [Abstract][Full Text] [Related]
20. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study.
Šoupal J; Petruželková L; Grunberger G; Hásková A; Flekač M; Matoulek M; Mikeš O; Pelcl T; Škrha J; Horová E; Škrha J; Parkin CG; Svačina Š; Prázný M
Diabetes Care; 2020 Jan; 43(1):37-43. PubMed ID: 31530663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
